Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Asthma

Recruiting

Investigational

Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

Investigational

Estonia

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Obesity+1

Recruiting

Registered drug

Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

Registered drug

Estonia

Participants:18–64 years · 65+ years
Substances:Granisetron

Contact Research Centre

Coagulation factor X level

Recruiting

InvestigationalNo placebo

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:VMX-C001

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Acute lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Asparaginase

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

Estonia

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Investigational

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Investigational

Estonia

Participants:18–64 years · 65+ years
Substances:BLEXIMENIB

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Registered drugNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Major depression

Recruiting

InvestigationalNo placebo

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo

Estonia

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Major depression

Recruiting

Investigational

Study of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment

Investigational

Estonia

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Varicella

Recruiting

Registered drugNo placebo

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Registered drugNo placebo

Estonia

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896

Contact Research Centre

Varicella

Recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Registered drugNo placebo

Estonia

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896

Contact Research Centre

Find therapies in clinical trials near you – page 2

143 trials match your criteria

Asthma

Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

Obesity+1

Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

Coagulation factor X level

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

Small cell lung cancer

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Acute lymphocytic leukaemia

Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

Secondary progressive multiple sclerosis

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Acute myeloid leukaemia

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Plasma cell myeloma

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Major depression

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

Major depression

Study of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment

Varicella

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Varicella

Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.